Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$510M |
| 2 |
Pfizer
PFE
|
+$265M |
| 3 |
Gilead Sciences
GILD
|
+$212M |
| 4 |
Comcast
CMCSA
|
+$191M |
| 5 |
Meta Platforms (Facebook)
META
|
+$184M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$369M |
| 2 |
SIAL
SIGMA - ALDRICH CORP
SIAL
|
+$330M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
+$230M |
| 4 |
Amgen
AMGN
|
+$223M |
| 5 |
Teva Pharmaceuticals
TEVA
|
+$145M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.46% |
| 2 | Healthcare | 12.72% |
| 3 | Financials | 10.51% |
| 4 | Industrials | 9.69% |
| 5 | Consumer Staples | 9.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Pacific Biosciences
PACB
$432M
| $20.8M | 0.05% |
+1,586,400
| New | +$14.2M |
|
|
COL
527
DELISTED
Rockwell Collins
COL
| $20.8M | 0.05% |
225,000
-302,171
| -57% | -$26.8M |
|
528
IPG Photonics
IPGP
$3.57B
| $20.7M | 0.05% |
231,795
-110,605
| -32% | -$9.48M |
|
529
Mitsubishi UFJ Financial
MUFG
$253B
| $20.6M | 0.04% |
3,309,200
+628,400
| +23% | +$4.06M |
|
530
Banco de Chile
BCH
$20.4B
| $20.6M | 0.04% |
1,115,125
+159,339
| +17% | +$3.06M |
|
531
JB Hunt Transport Services
JBHT
$26.1B
| $20.5M | 0.04% |
279,644
-395,010
| -59% | -$29.7M |
|
532
Quanex
NX
$893M
| $20.5M | 0.04% |
981,700
+98,900
| +11% | +$1.91M |
|
|
NBIS
533
Nebius Group N.V.
NBIS
$43.1B
| $20.5M | 0.04% |
1,301,500
-463,707
| -26% | -$6.94M |
|
534
Prestige Consumer Healthcare
PBH
$2.45B
| $20.4M | 0.04% |
396,100
+239,700
| +153% | +$11.9M |
|
535
EQT Corp
EQT
$32.3B
| $20.4M | 0.04% |
717,349
+675,849
| +1,629% | +$22.7M |
|
536
MSC Industrial Direct
MSM
$6.97B
| $20.3M | 0.04% |
360,900
+303,700
| +531% | +$18.4M |
|
|
MRO
537
DELISTED
Marathon Oil Corporation
MRO
| $20.3M | 0.04% |
1,611,572
+1,212,726
| +304% | +$20.4M |
|
538
BioMarin Pharmaceuticals
BMRN
$12B
| $20.3M | 0.04% |
193,571
-69,000
| -26% | -$7.21M |
|
|
INFN
539
DELISTED
Infinera Corporation Common Stock
INFN
| $20.3M | 0.04% |
1,117,800
+740,600
| +196% | +$14.7M |
|
|
WIBC
540
DELISTED
WILSHIRE BANCORP INC
WIBC
| $20.2M | 0.04% |
1,752,200
-252,580
| -13% | -$2.87M |
|
|
ZNGA
541
DELISTED
ZYNGA INC. CL A COMMON
ZNGA
| $20.2M | 0.04% |
7,548,373
+7,094,370
| +1,563% | +$17.9M |
|
542
FirstService
FSV
$6.58B
| $20.2M | 0.04% |
500,221
+46,121
| +10% | +$1.7M |
|
|
ARR
543
Armour Residential REIT
ARR
$2.04B
| $20.2M | 0.04% |
185,560
+68,460
| +58% | +$7.18M |
|
|
KKD
544
DELISTED
KRISPY KREME DOUGHNUTS INC
KKD
| $20.1M | 0.04% |
1,334,029
+321,665
| +32% | +$4.57M |
|
545
Grupo Aeroportuario del Sureste
ASR
$8.14B
| $20.1M | 0.04% |
142,900
+12,300
| +9% | +$1.88M |
|
546
Mativ Holdings
MATV
$482M
| $20.1M | 0.04% |
478,300
-46,883
| -9% | -$1.87M |
|
547
First Merchants
FRME
$2.74B
| $20.1M | 0.04% |
789,034
+29,100
| +4% | +$766K |
|
548
REX American Resources
REX
$1.4B
| $20.1M | 0.04% |
2,225,400
+156,000
| +8% | +$1.44M |
|
|
WNR
549
DELISTED
Western Refining Inc
WNR
| $20M | 0.04% |
561,300
+293,700
| +110% | +$12.6M |
|
|
DHC
550
Diversified Healthcare Trust
DHC
$2.23B
| $20M | 0.04% |
1,347,200
+720,029
| +115% | +$10.8M |
|
Similar funds
Renaissance Technologies's Q4 2015 Portfolio in Review
As of Q4 2015, Renaissance Technologies held 3,639 positions worth $45.9B, up 9.5% from $41.9B the previous quarter. Its ten largest holdings account for 9.3% of the portfolio.
Renaissance Technologies deployed $3.07B of net new capital in Q4 2015, opening 509 new positions and adding to 1,872 existing holdings. Its largest new stake was Apple: 17,852,932 shares worth $470M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 11% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $369M trimmed.
- Renaissance Technologies's largest Q4 2015 buy was Apple: 17,852,932 shares worth $470M.
- Renaissance Technologies added most to Gilead Sciences in Q4 2015, an estimated $212M increase.
- Renaissance Technologies's biggest Q4 2015 reduction was Alphabet (Google) Class C, cutting an estimated $369M.
- Renaissance Technologies fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $330M.
- Renaissance Technologies's ten largest holdings make up 9.3% of its $45.9B portfolio in Q4 2015.
- Renaissance Technologies opened 509 new positions and closed 386 in Q4 2015.
- Renaissance Technologies's portfolio value rose 9.5% quarter-over-quarter to $45.9B.
Based on Renaissance Technologies's 13F filing for Q4 2015, filed 11 Feb 2016.